If we fail to scale manufacturing in the United States, then our best bio-innovations will be brewed in China.

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

Stanford University genetics professor Dr. Stanley Cohen paid $29.2 million to settle a lawsuit over misleading claims he made about Nuredis Inc., his now-dissolved biotechnology company.

“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...

If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions ...

The broad field of biotechnology and applied microbiology covers topics on the manipulation of living organisms to make products or solve problems to meet human needs. Students in this field study ...

For decades, the U.S. biotech industry has thrived in hubs such as Boston-Cambridge and the San Francisco Bay Area, fueled by talent streaming from top academic centers like Massachusetts Institute of ...

Promising biotech companies could become attractive ... Vera Therapeutics (NASDAQ:VERA) later announced a licensing agreement with Stanford University for VT-109, a fusion protein designed to ...